Corrigendum to “Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study” [Eur. J. Cancer, vol. 205 (2024) 114119]
| Autor: | Noujaim, Jonathan, Gupta, Abha A., Holloway, Caroline L., Saleh, Ramy, Srikanthan, Amirrtha, Lemieux, Christopher, Soroka, Hagit Peretz, Tibout, Pauline, Turcotte, Robert, Feng, Xiaolan, Abdul Razak, Albiruni R., Costa, Philippos |
|---|---|
| Zdroj: | In European Journal of Cancer September 2024 208 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect